107 related articles for article (PubMed ID: 21646770)
1. [Molecular pathogenesis by human T-cell leukemia virus type 1].
Matsuoka M
Rinsho Ketsueki; 2011 May; 52(5):256-62. PubMed ID: 21646770
[No Abstract] [Full Text] [Related]
2. [Mechanism of leukemogenesis by human T-cell leukemia virus type I: from infection with HTLV-I to the onset of adult T-cell leukemia].
Matsuoka M
Rinsho Ketsueki; 2006 Dec; 47(12):1493-501. PubMed ID: 17233467
[No Abstract] [Full Text] [Related]
3. [Adult T-cell leukemia induced by HTLV-1: before and after HBZ].
Duc Dodon M; Mesnard JM; Barbeau B
Med Sci (Paris); 2010 Apr; 26(4):391-6. PubMed ID: 20412744
[TBL] [Abstract][Full Text] [Related]
4. [Recent progress in ATL and HTLV-1 research].
Matsuoka M
Rinsho Ketsueki; 2008 Oct; 49(10):1508-14. PubMed ID: 18833935
[No Abstract] [Full Text] [Related]
5. The HBZ gene, a key player in HTLV-1 pathogenesis.
Matsuoka M; Green PL
Retrovirology; 2009 Aug; 6():71. PubMed ID: 19650892
[TBL] [Abstract][Full Text] [Related]
6. HTLV-I basic leucine zipper factor gene mRNA supports proliferation of adult T cell leukemia cells.
Satou Y; Yasunaga J; Yoshida M; Matsuoka M
Proc Natl Acad Sci U S A; 2006 Jan; 103(3):720-5. PubMed ID: 16407133
[TBL] [Abstract][Full Text] [Related]
7. Human T-cell leukemia virus type 1 (HTLV-1) and leukemic transformation: viral infectivity, Tax, HBZ and therapy.
Matsuoka M; Jeang KT
Oncogene; 2011 Mar; 30(12):1379-89. PubMed ID: 21119600
[TBL] [Abstract][Full Text] [Related]
8. Does the HBZ gene represent a new potential target for the treatment of adult T-cell leukemia?
Barbeau B; Mesnard JM
Int Rev Immunol; 2007; 26(5-6):283-304. PubMed ID: 18027202
[TBL] [Abstract][Full Text] [Related]
9. [HTLV-1 bZIP Factor (HBZ) gene has a growth-promoting effect on adult T-cell leukemia cells].
Satou Y; Yasunaga J; Yoshida M; Matsuoka M
Rinsho Ketsueki; 2008 Nov; 49(11):1525-9. PubMed ID: 19047782
[No Abstract] [Full Text] [Related]
10. Guest editorial: a new era of ATL and HTLV-1 research.
Matsuoka M
Int J Hematol; 2011 Nov; 94(5):429. PubMed ID: 21969188
[No Abstract] [Full Text] [Related]
11. Human T-cell leukemia virus type 1 Tax oncoprotein represses the expression of the BCL11B tumor suppressor in T-cells.
Takachi T; Takahashi M; Takahashi-Yoshita M; Higuchi M; Obata M; Mishima Y; Okuda S; Tanaka Y; Matsuoka M; Saitoh A; Green PL; Fujii M
Cancer Sci; 2015 Apr; 106(4):461-5. PubMed ID: 25613934
[TBL] [Abstract][Full Text] [Related]
12. Mechanisms of HTLV-1 persistence and transformation.
Boxus M; Willems L
Br J Cancer; 2009 Nov; 101(9):1497-501. PubMed ID: 19861996
[TBL] [Abstract][Full Text] [Related]
13. Implication of the HTLV-I bZIP factor gene in the leukemogenesis of adult T-cell leukemia.
Satou Y; Matsuoka M
Int J Hematol; 2007 Aug; 86(2):107-12. PubMed ID: 17875522
[TBL] [Abstract][Full Text] [Related]
14. [HTLV-1: Recent topics in epidemiologic, basic and clinical research].
Yasunaga J; Matsuoka M
Uirusu; 2013; 63(2):165-74. PubMed ID: 25366051
[TBL] [Abstract][Full Text] [Related]
15. HTLV-1 HBZ suppresses AP-1 activity by impairing both the DNA-binding ability and the stability of c-Jun protein.
Matsumoto J; Ohshima T; Isono O; Shimotohno K
Oncogene; 2005 Feb; 24(6):1001-10. PubMed ID: 15592508
[TBL] [Abstract][Full Text] [Related]
16. HTLV-1 bZIP factor HBZ promotes cell proliferation and genetic instability by activating OncomiRs.
Vernin C; Thenoz M; Pinatel C; Gessain A; Gout O; Delfau-Larue MH; Nazaret N; Legras-Lachuer C; Wattel E; Mortreux F
Cancer Res; 2014 Nov; 74(21):6082-93. PubMed ID: 25205102
[TBL] [Abstract][Full Text] [Related]
17. Preferential selection of human T-cell leukemia virus type 1 provirus lacking the 5' long terminal repeat during oncogenesis.
Miyazaki M; Yasunaga J; Taniguchi Y; Tamiya S; Nakahata T; Matsuoka M
J Virol; 2007 Jun; 81(11):5714-23. PubMed ID: 17344291
[TBL] [Abstract][Full Text] [Related]
18. HTLV-1 bZIP factor gene: Its roles in HTLV-1 pathogenesis.
Matsuoka M
Mol Aspects Med; 2010 Oct; 31(5):359-66. PubMed ID: 20599553
[TBL] [Abstract][Full Text] [Related]
19. Potential for molecular targeted therapy for adult T-cell leukemia/lymphoma.
Faris M
Int Rev Immunol; 2008; 27(1-2):71-8. PubMed ID: 18300056
[TBL] [Abstract][Full Text] [Related]
20. [ATL and AIDS].
Matsuoka M
Rinsho Ketsueki; 2003 May; 44(5):294-301. PubMed ID: 12822403
[No Abstract] [Full Text] [Related]
[Next] [New Search]
